|
|
Line 3: |
Line 3: |
|
| |
|
| ='''Snus'''= | | ='''Snus'''= |
| | |
| | ===2022: [https://f1000research.com/articles/9-1225#f1 Nicotine products relative risk assessment: an updated systematic review and meta-analysis [version 2; peer review: 1 approved, 1 approved with reservations<nowiki>]</nowiki> Previously titled: Nicotine products relative risk assessment: a systematic review and meta-analysis]=== |
| | *In this update, 70 new studies were added to the synthesis, making a total of 123 studies included. All combustible tobacco products score between 40 and 100, with bidis and smokeless (rest of world) also in this range. All other products have a combined risk score of 10 or less, including U.S. chewing tobacco, U.S. dipping tobacco, snus, heat-not-burn tobacco, electronic cigarettes, non-tobacco pouches and nicotine replacement therapy. |
| | *Citation: Murkett R, Rugh M and Ding B. Nicotine products relative risk assessment: an updated systematic review and meta-analysis [version 2; peer review: 1 approved, 1 approved with reservations]. F1000Research 2022, 9:1225 (https://doi.org/10.12688/f1000research.26762.2) |
|
| |
|
| ===2019: [https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-019-0335-1 Snus: a compelling harm reduction alternative to cigarettes]=== | | ===2019: [https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-019-0335-1 Snus: a compelling harm reduction alternative to cigarettes]=== |